Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $41.70 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $25.00 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $16.70 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $16.70 | 1 | Merck Sharp & Dohme LLC ($16.70) |
| 2022 | $25.00 | 1 | Novo Nordisk Inc ($25.00) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2023 | Merck Sharp & Dohme LLC | M-M-R II (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: VACCINE | ||||||
| 02/04/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 329 | 521 | $56,079 | $21,838 |
| 2022 | 5 | 279 | 434 | $47,504 | $18,604 |
| 2021 | 5 | 255 | 440 | $75,668 | $23,149 |
| 2020 | 19 | 591 | 12,792 | $341,501 | $103,516 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 252 | $34,380 | $13,011 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 141 | 218 | $19,480 | $7,981 | 41.0% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2023 | 28 | 28 | $1,736 | $613.76 | 35.4% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 20 | 23 | $483.00 | $232.30 | 48.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 236 | $31,860 | $12,049 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 156 | $13,728 | $5,746 | 41.9% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2022 | 16 | 16 | $992.00 | $353.02 | 35.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 14 | 14 | $672.00 | $334.20 | 49.7% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 12 | 12 | $252.00 | $122.03 | 48.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 115 | 203 | $35,202 | $12,107 | 34.4% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 25 | 59 | $22,951 | $5,453 | 23.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 91 | 123 | $14,226 | $4,959 | 34.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 43 | $2,537 | $351.55 | 13.9% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2021 | 11 | 12 | $752.00 | $277.80 | 36.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 11 | 2,700 | $95,796 | $42,018 | 43.9% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 33 | 197 | $76,633 | $18,761 | 24.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 132 | 232 | $55,728 | $13,015 | 23.4% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2020 | 11 | 3,510 | $20,871 | $5,541 | 26.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 100 | 132 | $21,417 | $5,002 | 23.4% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 50 | 256 | $16,333 | $3,340 | 20.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 39 | 41 | $2,357 | $2,349 | 99.7% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2020 | 23 | 198 | $11,286 | $2,204 | 19.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 13 | 45 | $8,819 | $2,104 | 23.9% |
| 96417 | Infusion of different chemotherapy drug or substance into a vein up to 1 hour | Office | 2020 | 11 | 40 | $7,000 | $1,883 | 26.9% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2020 | 13 | 430 | $2,435 | $1,466 | 60.2% |
About Stormy Jensen, NP
Stormy Jensen, NP is a Nurse Practitioner healthcare provider based in Miles City, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2012. The National Provider Identifier (NPI) number assigned to this provider is 1477816791.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stormy Jensen, NP has received a total of $41.70 in payments from pharmaceutical and medical device companies, with $16.70 received in 2023. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($41.70).
As a Medicare-enrolled provider, Jensen has provided services to 1,454 Medicare beneficiaries, totaling 14,187 services with total Medicare billing of $167,107. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family
- Location Miles City, MT
- Active Since 06/21/2012
- Last Updated 12/14/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1477816791
Products in Payments
- Rybelsus (Drug) $25.00
- M-M-R II (Biological) $16.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Miles City
Joy Huber, Fnp, FNP
Nurse Practitioner — Payments: $134.92
Kate Marsh
Nurse Practitioner — Payments: $27.50
David Smith, Aprn, APRN
Nurse Practitioner — Payments: $27.44
Nicole Zavatsky
Nurse Practitioner — Payments: $12.41
Rosemary Malloy, Fnp, FNP
Nurse Practitioner